Spinal Muscular Atrophy Type 3: Clinical Trials

1 trial for Spinal Muscular Atrophy Type 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Spinal Muscular Atrophy Type 3: new trials by email Literature Review of Spinal Muscular Atrophy Type 3 trials Research Report on Spinal Muscular Atrophy Type 3

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
GC101 - Spinal Muscular Atrophy Type 3
Phase 1 / Phase 2RecruitingGeneCradle Inc212024-05-102026-11-17

Narrower conditions

Spinal Muscular Atrophies of Childhood (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Motor Neuron Disease (1)  ·  Muscular Atrophy, Spinal (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Spinal Cord Diseases (1)

Sponsors

GeneCradle Inc (1)

Countries

China (1)